{"id":"NCT05132127","sponsor":"Sanofi","briefTitle":"Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan","officialTitle":"An Open-label Study for Sutimlimab in Participants With Cold Agglutinin Disease (CAD) Who Have Completed the CARDINAL Study (BIVV009-03/EFC16215, Part B) or CADENZA Study (BIVV009-04/EFC16216, Part B) in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-11-11","primaryCompletion":"2022-11-15","completion":"2022-11-15","firstPosted":"2021-11-24","resultsPosted":"2023-10-03","lastUpdate":"2023-10-03"},"enrollment":7,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cold Agglutinin Disease"],"interventions":[{"type":"DRUG","name":"sutimlimab","otherNames":[]}],"arms":[{"label":"Sutimlimab","type":"EXPERIMENTAL"}],"summary":"This was a multi-center, single treatment-group, open-label study to provide sutimlimab to the adult participants with cold agglutinin disease (CAD) who had completed the CARDINAL (NCT number: NCT03347396) or CADENZA (NCT number: NCT03347422) studies and benefitted from sutimlimab treatment in Japan.\n\nâ€¢ Study and treatment duration: the period between the participant's completion of the CARDINAL and CADENZA studies and sutimlimab or other appropriate CAD therapy becoming commercially available to participants in Japan.","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs)","timeFrame":"From first dose of study intervention up to 9 weeks after the last dose of study intervention (maximum duration: 49 weeks)","effectByArm":[{"arm":"Sutimlimab","deltaMin":7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":4},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":7},"commonTop":["Back Pain","Pyrexia","Cystitis","Gingivitis","Nasopharyngitis"]}}